Tom Schell

IRAP Therapy In Horses

Joint disease in the horse is the number one cause of ongoing lameness and a result of many factors including excessive or ongoing trauma, genetics, diet and lifestyle influences.  Degeneration within the joint leads to cartilage erosion, remodeling of the joint, ongoing pain and reduced range of motion in more severe cases.  It is a condition that is best prevented and managed in the early stages versus in the advanced stages.

 

Therapies for joint disease in the horse now includes joint injections with corticosteroids, hyaluronic acid, polysulfated glycosaminoglycans and over the past several years, there is a new kid on the block termed IRAP or Interleukin-1 Receptor Antagonist Protein. IRAP therapy is supposed to help manage the inflammation and joint deterioration more effectively through the use of the body’s own natural resources.

IRAP Therapy In Horses Read More »

Performance Enhancing or Performance Restoring

I read the line “performance enhancing or performance restoring” as part of a quote from a regulatory veterinarian in a discussion regarding drug use in the equine industry.  I like the line, because it helps to create potential criteria that determines a drug or herb’s potential use and implications. We all want to achieve the best, win that competition, but we have to ask what are we doing with these medications?  Are we trying to enhance performance in an animal that may not be able to perform at the desired level, inherantly, or are we trying to restore performance to an animal that has become compromised to some degree?

Performance Enhancing or Performance Restoring Read More »